Related Experiment Video
Updated: Jun 13, 2026
05:08
A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease
Published on: March 1, 2022
Inflammatory activity in Crohn's disease: CE-US.
Vincenzo Migaleddu1, Emilio Quaia, Domenico Scanu
1SMIRG FOUNDATION, Sardinian Mediterranean Imaging Research Group-No Profit Foundation/Diagnostic Imaging Unit, Sassari, Italy. migaleddu@smirg.org
Abdominal Imaging
|May 14, 2010
Summary
Contrast enhanced ultrasound (CE-US) offers a less invasive, accurate method for evaluating Crohn
Area of Science:
- Gastroenterology
- Medical Imaging
- Ultrasound Technology
Background:
- Assessing Crohn's disease (CD) inflammatory activity is vital for patient management.
- Current methods rely on clinical data and imaging, with contrast-enhanced cross-sectional techniques (CE-US, CE-CT, CE-MR) being common.
- CE-US presents advantages such as being less invasive, more comfortable, and radiation-free.
Purpose of the Study:
- To highlight the role of CE-US in evaluating Crohn's disease inflammatory activity.
- To explore the potential of CE-US in differentiating causes of bowel-wall thickening.
- To introduce US elastography for assessing fibrosis in CD.
Main Methods:
- Utilizing contrast-enhanced ultrasound (CE-US) for imaging.
- Analyzing CE-US for quantitative and qualitative assessment of CD inflammation.
- Incorporating ultrasound elastography to evaluate bowel-wall stiffness and fibrosis.
Main Results:
- CE-US demonstrates significant diagnostic accuracy in evaluating CD inflammatory activity.
- CE-US can characterize bowel-wall thickening, distinguishing neovascularization, edema, and fibrosis.
- US elastography shows promise in assessing fibrosis, a key aspect of CD evolution.
Conclusions:
- CE-US is an effective, well-tolerated imaging modality for Crohn's disease assessment.
- CE-US aids in differentiating inflammatory components of bowel thickening.
- The integration of US elastography offers advanced fibrosis evaluation in CD.
Related Concept Videos
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
01:20Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
01:26Inflammatory Bowel Disease I: Introduction
Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...